Investor

Taiwan-based health tech startup iWEECARE announced that it has raised $1M in Pre-Series A funding, led by Singapore-based Verge HealthTech Fund, alongside Taiwan/US-based Translink Capital and Darwin Venture.

This includes a grant from the Innovate UK agency and investment from 24 Haymarket.

M Ventures led the round with participation from Grey Sky Venture Partners, VI Partners AGG, Alpana Ventures and FYRFLY Ventures. 

The Singaporean company will be moving its headquarters to Boston. 

Theranica, an Israel-based biomedical technology company focused on developing advanced electroceuticals for migraine and other prevalent diseases, announced that Omron Ventures has joined its $35M series B funding round, which was announced earlier this March.

Private equity firm Warburg Pincus merged the two companies, promising to support existing clients. 

The New York City-based company will be scaling its brand, expanding its logistics and continuing work on its core technology.

Sydney, Australia-based tech accelerator BlueChilli and Enterprise Singapore, an economic agency under the Singapore Ministry and Trade and Industry, announced that they will partner to launch a Singapore-based health tech accelerator to spur innovation and build startups that address health challenges and opportunities in Southeast Asia.

Erika Cheung recently launched the Ethics in Entrepreneurship venture in Hong Kong and the US to help startups navigate ethics in innovation. 

Established in the US in 2013, Shanghai-headquartered QTC Care, a healthcare platform that uses AI to streamline treatment recovery and disease prevention, announced that it has raised $7M in series A funding.